MKI67 and breast carcinoma: Although the results of the study show that a high Ki-67 index is associated with high risk of recurrence and poor survival in patients with early breast cancer [15, 16] and responds well to neoadjuvant chemotherapy [17],because poor reproducibility between observers and the lack of a standardized scoring system [10], its clinical application is still under debate.